Dipyrone-related granulocytopenia. Case report

Audifarma |   | Tiempo de lectura: Min

Introduction: Dipyrone has been positioned in several countries
as one of the first over-the-counter options for pain management.
Its possible adverse effects are known worldwide; among them,
agranulocytosis is the most lethal, with a

  • Tema: Farmacovigilancia
  • Autores: Jorge Enrique Machado-Alba, Leidy Viviana Sánchez-Morales, Luisa Fernanda Rodríguez-Ramírez
  • Idiomas: Inglés
  • Palabras clave: "Dipirona, Agra- nulocitosis, Farmacovigilancia, Efectos Adversos, Reporte de casoDipyrone, Agranulo- cytosis, Pharmacovigilance, Ad- verse effects, Case Report"
¿Cómo citar este artículo?
Machado-Alba JE, Sánchez-Morales LV, Rodriguez-Ramirez LF. Dipyrone-related granulocytopenia. Case report. Colombian Journal of Anesthesiology. 2018;46:327-330. Enlace: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-33472018000400327&lng=en&nrm=iso
2018